.png)
Analyzed data points: 29,425
Specialties: Oncology; Pulmonology
Countries analyzed: 79
Reach: 72,538
Analysis of G-Med Physician Posts and Comments on the Topic of Lung Cancer
Main Concerns of G-Med Physicians on the Topic of Lung Cancer
Diagnosis of Tumor Tissue (16% of physician discussions): Concerns about the accurate diagnosis of tumor tissue, especially in cases where the tumor has abundant pools of extracellular mucin and glandular structures.
Next Generation Sequencing (15%): The need for next-generation sequencing of tumor tissue to identify specific genetic markers such as ALK, EGFR, ROS1, BRAF, RET, C-MET, MSI, PDL-1, and NTRK.
Adverse Reactions to Treatments (11%): Concerns about serious adverse reactions to lung cancer treatments, such as drug induced liver injury (DILI), lung inflammation, arrythmias, and loss of vision.
Increasing Frequency of Pneumonia (8%): Physicians expressed concerns about the increasing frequency of pneumonia in lung cancer patients and the difficulty in isolating an organism responsible for it.
Patient Preparation Issues (6%): Issues related to patient preparation, including the use of erythropoietin analogs to raise baseline hemoglobin levels before surgery.
CAR-T Treatment (5%): The potential of CAR-T treatment to improve patient outcomes and the need for further research on this new treatment approach.
Intraoperative Management (5%): Concerns regarding intraoperative management, including the use of cell savers, deliberate hypotension, anti-Trendelenburg positioning, and central venous or pulmonary artery blood gas monitoring.
Main Points Concerning Lung Cancer Diagnosis, Treatment, and Follow-up
Diagnosis
Efforts for Early Detection: There's an emphasis on the need for early detection and timely treatment through evidence-based guidelines.
Age-Related Detection Issues: Some physicians note issues with age-related detection, where older patients may have delayed or missed diagnoses.
Treatment
Chemotherapy Regimens: Common treatments include cisplatin and pemetrexed, with some patients undergoing maintenance therapy with pemetrexed.
Adverse Reactions: Concerns about severe adverse reactions to treatments, including DILI, lung inflammation, and more.
Next Generation Sequencing: The use of next-generation sequencing to identify genetic markers and tailor treatment plans.
Palliative Care: Physicians frequently discuss options for palliative treatment for advanced-stage patients.
Innovative Treatments: CAR-T treatment is a new area of interest in the field of lung cancer with the potential to improve patient outcomes.
Follow-up
Monitoring and Follow-up Scans: Regular follow-up scans, such as CT scans, are crucial for monitoring disease progression and detecting new disease and complications.
Proactive Monitoring: There is a need for proactive monitoring to manage cancer risk post-referral.
Management of Side Effects: Physicians discuss the management of side effects during the follow-up period, such as intensified low back pain.
Unblinding Trials: Some clinical trials are unblinded early due to overwhelming efficacy, indicating successful treatments.
Intraoperative Management: Detailed intraoperative management strategies are discussed as a means of mitigating potential operative complications.
Geographical Differences in Physicians’ Lung Cancer Concerns:
Austria: Focus on new treatment methods like CAR-T and their implications.
Canada: Recurrent pneumonia and diagnostic challenges in lung cancer patients.
France: Managing lung cancer in patients with a history of other cancers.
Australia: Emphasis on patient rights and health communication.
Brazil: Concerns about tobacco addiction and its role in lung cancer.
These insights can help tailor communication and support strategies for physicians in different regions, addressing their specific concerns and focal points more effectively.
Engagement Recommendations:
Based on the insights gathered from physicians' discussions on G-Med, it’s clear that there are some knowledge gaps on the topic of accurate diagnosis of lung cancer, which could be closed by an awareness campaign.
G-Med's Awareness Package could be a good fit here.